Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta cir. bras ; 34(1): e20190010000005, 2019. graf
Article Dans Anglais | LILACS | ID: biblio-983682

Résumé

Abstract Purpose: To investigate the role of PI3k/Akt signal pathway in the protective effects of propofol on intestinal and lung injury induced by intestinal ischemia/reperfusion(I/R). Methods: Male Sprague-Dawley rats were subjected to 45 min of ischemia by occluding the superior mesenteric artery and to 2h of reperfusion to establish the model of I/R. Twenty four rats were randomly divided into four groups: Sham, intestinal I/R (II/R), propofol (P), wortmannin (W). In groups P, W, propofol was injected intravenously and continuously at the onset of reperfusion via infusion pump. PI3K inhibitor (wortmannin) was administered intravenously in group W 25 min before ischemia. Intestinal tissues and lung tissues were obtained for determination of histologic injury, wet/dry weight ratio, malondialdehyde (MDA) levels, superoxide dismutase (SOD) and myeloperoxidase (MPO) activities. Meanwhile, the expressions of caspase-3 and phosphorylated Akt (p-Akt) in intestines and lungs were detected by western blot. Results: Propofol treatment alleviated intestinal and lung morphological changes which were observed in II/R group,Moreover, wet/dry weight ratio, the MDA level, MPO activity and expression of caspase-3 were significantly decreased whereas the SOD activity and p-Akt expression were significantly increased. Notably, the protections were significantly reversed by pretreatment of wortmannin. Conclusion: PI3K/Akt pathway activation play a critical role in the protective effects of propofol on intestinal and lung injury induced by ischemia/reperfusion.


Sujets)
Animaux , Mâle , Rats , Lésion d'ischémie-reperfusion/traitement médicamenteux , Propofol/pharmacologie , Anesthésiques intraveineux/pharmacologie , Phosphatidylinositol 3-kinases/physiologie , Protéines proto-oncogènes c-akt/physiologie , Lésion pulmonaire/prévention et contrôle , Ischémie mésentérique/traitement médicamenteux , Lésion d'ischémie-reperfusion/métabolisme , Transduction du signal/physiologie , Rat Sprague-Dawley , Modèles animaux de maladie humaine , Ischémie mésentérique/métabolisme
SÉLECTION CITATIONS
Détails de la recherche